inhibitory activity and their stability against most P-lactamases are expected to find wide clinical application in therapy for infections caused by P-lactamase-producing pathogens (12) . However, carbapenems are rapidly metabolized in vivo, resulting in poor urinary recovery, because they are susceptible to renal dehydropeptidase I (4) . Renal dipeptidase has been purified from human (10) and swine (2, 3) kidney.
We have previously reported on the comparative stability of newly introduced P-lactam antibiotics against purified swine renal dipeptidase (8) . Knowledge of in vivo metabolism and of in vitro hydrolysis by renal dehydropeptidase of carbapenem antibiotics is essential for the practical chemical evaluation of carbapenem derivatives. This paper deals with the enzymatic and physicochemical properties of purified human renal dehydropeptidase I and the comparative stability of some 1-lactam compounds against dehydropeptidase I purified from human kidney.
Imipenem and the renal dehydropeptidase I inhibitor cilastatin were supplied by Merck Sharp & Dohme, Rahway, N.J. Carpetimycins A and B were gifts from Kowa Co., Tokyo, Japan. Sch 29,482 was supplied by Schering Corp., Bloomfield, N.J. Aztreonam was obtained from the Squibb Institute for Medical Research, Princeton, N.J. Penicillin G and cephaloridine were commercially available.
Fresh human kidney tissue (100 g) was homogenized in a Biomixer (BM-2; Nihon Seiki Co., Ltd., Tokyo, Japan) with 300 ml of ice water. The homogenate was centrifuged at 10,000 x g for 30 min. The supernatant was dialyzed against 2 mM Tris hydrochloride buffer (pH 8.0) for 18 h at 4°C. The enzyme was applied to a DEAE-cellulose column (3 by 30 cm) equilibrated with the same buffer. After the column was washed with 300 ml of this buffer, the dehydropeptidase was eluted with a linear concentration gradient of 0 to 0.4 M NaCl in this buffer. The active fractions of dehydropeptidase were collected and concentrated (3). Electrofocusing (11) was performed on a carrier ampholyte (pH 3.5 to 10.0) with a sucrose gradient in a 110-ml column at below 4°C for more than 48 h. The contents of the column were cut into 2-ml fractions, and each fraction was assayed for enzyme activity and pH. After dialysis of the enzyme solution, gel filtration with Sephadex G-200 was carried out. Electrofocusing and * Corresponding author. gel filtration were repeated as the final step. The concentration of protein was estimated by the Lowry method (7).
Hydrolysis was assayed spectrophotometrically as described previously (2, 8, 13) . One unit of the enzyme was defined as the amount of the enzyme which hydrolyzed 1 ,umol of a substrate per min at 35°C.
A summary of the purification procedure and of recovery after each step is shown in Table 1 . Dehydropeptidase was purified about 120-fold, with an overall recovery of 6%. The final preparation had a specific activity of 6.55 U/mg of protein and gave a single band by sodium dodecyl sulfatepolyacrylamide gel electrophoresis. The molecular weight of the enzyme was estimated to be 135,000 by gel filtration on a Sephadex G-200 column (1). The purified enzyme was dissociated by treatment with sodium dodecyl sulfate, and the molecular weights of the resulting subunits were estimated by polyacrylamide gel electrophoresis (6) . The data indicated that the enzyme dissociates to single subunits with molecular weights of 66,500, which suggests that the native enzyme exists as a dimer of two subunits with equal molecular weight. The isoelectric point was 4.75. The pH activity curve for the purified enzyme was determined with glycyldehydrophenylalanine as a substrate. The optimal pH was about 7.4. The optimal temperature and point of thermal stability of this enzyme were found to be above 80°C and up to 70°C, respectively.
The kinetic parameters of the enzyme are shown in Purification of human dehydropeptidase by a previously described treatment (8) was unsuccessful, since enzyme activity was lost. Shibamoto et al. (9) reported that PS-5 inactivating factor was fractionated by the differential cen-ANTIMICROB. AGENTS CHEMOTHER. trifugation method. The enzyme from human kidney was purified by centrifugation, DEAE-cellulose chromatography, electrofocusing, and gel filtration. Sugiura et al. (10) reported on the purification and properties of two dipeptidases obtained from human kidney. One of these dipeptidases, dipeptidase F, was very similar physicochemically but dissimilar enzymatically to our dehydropeptidase. The optimal pHs, optimal temperatures and thermal stabilities of our purified enzyme and dipeptidase F were 7.4 and 9.0, above 80 and 70°C, and stable up to 70 and 600C, respectively. Moreover, the effects of some metal ions on the activity of the two enzymes were very different. 
